4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-017035
Director acquired 1,174 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones James Director | 2023-12-01 | Other acquisition 10b5-1 | +72 | $1.69 | $122 | 31,305 | D |
| Jones James Director | 2023-12-04 | Other acquisition 10b5-1 | +64 | $1.72 | $110 | 31,369 | D |
| Jones James Director | 2023-12-05 | Other acquisition 10b5-1 | +72 | $1.69 | $122 | 31,441 | D |
| Jones James Director | 2023-12-06 | Other acquisition 10b5-1 | +72 | $1.70 | $122 | 31,513 | D |
| Jones James Director | 2023-12-07 | Other acquisition 10b5-1 | +34 | $1.65 | $56 | 31,547 | D |
| Jones James Director | 2023-12-08 | Other acquisition 10b5-1 | +72 | $1.83 | $132 | 31,619 | D |
| Jones James Director | 2023-12-11 | Other acquisition 10b5-1 | +82 | $1.85 | $152 | 31,701 | D |
| Jones James Director | 2023-12-12 | Other acquisition 10b5-1 | +87 | $1.77 | $154 | 31,788 | D |
| Jones James Director | 2023-12-13 | Other acquisition 10b5-1 | +82 | $1.80 | $148 | 31,870 | D |
| Jones James Director | 2023-12-14 | Other acquisition 10b5-1 | +82 | $1.86 | $153 | 31,952 | D |
| Jones James Director | 2023-12-15 | Other acquisition 10b5-1 | +82 | $1.89 | $155 | 32,034 | D |
| Jones James Director | 2023-12-18 | Other acquisition 10b5-1 | +81 | $1.80 | $146 | 32,115 | D |
| Jones James Director | 2023-12-19 | Other acquisition 10b5-1 | +81 | $1.73 | $140 | 32,196 | D |
| Jones James Director | 2023-12-20 | Other acquisition 10b5-1 | +124 | $1.76 | $218 | 32,320 | D |
| Jones James Director | 2023-12-21 | Other acquisition 10b5-1 | +87 | $1.70 | $148 | 32,407 | D |
Loading xslF345X05/marketforms-63938.xml…